Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis? - PubMed (original) (raw)

Is Helicobacter pylori associated hypergastrinaemia due to the bacterium's urease activity or the antral gastritis?

R S Chittajallu et al. Gut. 1991 Nov.

Abstract

Eradication of Helicobacter pylori is associated with a fall in serum gastrin but the way in which the infection raises the serum gastrin concentration is not clear. It may be related to the ammonia produced by the bacterium's urease stimulating gastrin release by the antral G cells. Alternatively, the antral gastritis induced by the infection may modify the regulation of gastrin release. We have examined serum gastrin in 10 patients before and 24 hours after starting triple anti-H pylori treatment consisting of tripotassium dicitrato bismuthate 120 mg four times daily, metronidazole 400 mg three times daily, and amoxycillin 500 mg three times daily. The urease activity, assessed by the 20 minute value of the 14C-urea breath test, fell from a median of 176 (range 116-504) kg% dose/mmol CO2 x 100 pretreatment to 5 (2-15) at 24 hours (p less than 0.005). The median antral gastritis score was 6 (4-6) pretreatment and fell to 3 (2-5) at 24 hours (p less than 0.02), and this was due to resolution of the polymorphonuclear component. Despite this complete suppression of bacterial urease activity and partial resolution of antral gastritis the median basal gastrin concentration remained unchanged, being 57 ng/l (45-77) pretreatment and 59 ng/l (45-80) at 24 hours and the median integrated gastrin response to a standardised meal was also unaltered, being 4265 ng/l/min (range 1975-8350) and 4272 ng/l/min (range 2075-6495) respectively. These findings do not support a causal association between H pylori urease activity and hypergastrinaemia and show rapid improvement of antral gastritis after starting anti-H pylori treatment.

PubMed Disclaimer

Similar articles

• Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects.
  McColl KE, Fullarton GM, Chittajalu R, el Nujumi AM, MacDonald AM, Dahill SW, Hilditch TE. McColl KE, et al. Scand J Gastroenterol. 1991 Mar;26(3):339-46. doi: 10.3109/00365529109025052. Scand J Gastroenterol. 1991. PMID: 1853158
• Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects.
  el Nujumi AM, Dorrian CA, Chittajallu RS, Neithercut WD, McColl KE. el Nujumi AM, et al. Gut. 1991 Aug;32(8):866-70. doi: 10.1136/gut.32.8.866. Gut. 1991. PMID: 1885067 Free PMC article.
• Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
  Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Bianchi Porro G. Maconi G, et al. Am J Gastroenterol. 1997 Oct;92(10):1844-8. Am J Gastroenterol. 1997. PMID: 9382049
• [Helicobacter pylori, a rediscovered bacterium. Implication in gastroduodenal diseases].
  Sobhani I, Vallot T, Mignon M. Sobhani I, et al. Presse Med. 1995 Jan 14;24(2):67-73, 75-6, 78-9. Presse Med. 1995. PMID: 7899350 Review. French.
• [Mechanisms in hypergastrinemia in autoimmune atrophic gastritis and Helicobacter pylori infection].
  Deprez P, Calam J. Deprez P, et al. Acta Gastroenterol Belg. 1993 May-Aug;56(3-4):245-50. Acta Gastroenterol Belg. 1993. PMID: 8266764 Review. French.

Cited by

• Helicobacter pylori induction of the gastrin promoter through GC-rich DNA elements.
  Tucker TP, Gray BM, Eaton KA, Merchant JL. Tucker TP, et al. Helicobacter. 2010 Oct;15(5):438-48. doi: 10.1111/j.1523-5378.2010.00787.x. Helicobacter. 2010. PMID: 21083750 Free PMC article.
• Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.
  Taha AS, Russell RI. Taha AS, et al. Gut. 1993 May;34(5):580-3. doi: 10.1136/gut.34.5.580. Gut. 1993. PMID: 8504954 Free PMC article. No abstract available.
• Diversity in bacterium-host interactions within the species Helicobacter heilmannii sensu stricto.
  Joosten M, Blaecher C, Flahou B, Ducatelle R, Haesebrouck F, Smet A. Joosten M, et al. Vet Res. 2013 Jul 29;44(1):65. doi: 10.1186/1297-9716-44-65. Vet Res. 2013. PMID: 23895283 Free PMC article.
• Gastrin and somatostatin in Helicobacter pylori infected antral mucosa.
  Odum L, Petersen HD, Andersen IB, Hansen BF, Rehfeld JF. Odum L, et al. Gut. 1994 May;35(5):615-8. doi: 10.1136/gut.35.5.615. Gut. 1994. PMID: 7911115 Free PMC article.
• Optimizing acid suppression for treatment of acid-related diseases.
  Hunt RH, Cederberg C, Dent J, Halter F, Howden C, Marks IN, Rune S, Walt RP. Hunt RH, et al. Dig Dis Sci. 1995 Feb;40(2 Suppl):24S-49S. doi: 10.1007/BF02214870. Dig Dis Sci. 1995. PMID: 7859582 Review.

References

1. 1. Am J Gastroenterol. 1990 Apr;85(4):394-8 - PubMed
2. 1. Gastroenterology. 1970 Jan;58(1):1-14 - PubMed
3. 1. J Clin Invest. 1975 Mar;55(3):462-8 - PubMed
4. 1. Gut. 1991 Aug;32(8):866-70 - PubMed
5. 1. Gut. 1991 Jan;32(1):21-4 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • PubMed Central

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal